Brainstorm Cell Therapeutics: Caution Ahead Of ALS Phase II Data Seeking Alpha, 03 Jun 2016 Brainstorm Cell Therapeutics (NASDAQ: BCLI ) will soon release Phase II data on patients suffering from Amyotrophic Lateral…